<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04752969</url>
  </required_header>
  <id_info>
    <org_study_id>30012021</org_study_id>
    <nct_id>NCT04752969</nct_id>
  </id_info>
  <brief_title>The Effect of Thyroid Hormon Levels on the Corneal Measures</brief_title>
  <official_title>Can Thyroid Levels Affect Topographic, Densitometric and Aberrometric Values of the Cornea</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this cross-sectional comparative study, it is aimed to investigate the topographic&#xD;
      measurements,aberrometrics and densitometrics values of corneas in hypothyroid and&#xD;
      hyperthyroid patients compared to healthy individuals. A number of 20 hypothyroid patients&#xD;
      (group I), 20 hyperthyroid patients (group II), and 20 age-matched healthy controls (group&#xD;
      III) have been recruited. The Pentacam high resolution imaging system is used to determine&#xD;
      corneal topographic measurements,aberrometry and densitometry.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Thyroid hormone diseases can cause different symptoms and signs in the body according to the&#xD;
      hormone levels, particularly in the eyes. Corneal tissue can be affected by many biochemical&#xD;
      and hormonal factors, and many ocular surface and systemic diseases can affect the&#xD;
      cornea.Hyperthyroidism has been shown to cause symptoms such as conjunctival chemosis,&#xD;
      proptosis, increased intraocular pressure, limitation to globe movements due to the&#xD;
      restriction of extraocular muscles, increased orbital volume, increased risk of glaucoma with&#xD;
      inflammation in the trabecular meshwork and exposure keratopathy, especially in Graves'&#xD;
      disease. In the case of hypothyroidism, studies have shown fluid retention and edema in all&#xD;
      body tissues, thereby resulting in increased thickness in the cornea, as well as a decrease&#xD;
      in corneal hysteresis, which increases the risk of glaucoma. In this study, it is aimed to&#xD;
      assess whether thyroid hormone changes affect those parameters by objectively measuring&#xD;
      corneal changes via corneal topography, corneal densitometry and corneal aberrometry.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 15, 2020</start_date>
  <completion_date type="Actual">January 1, 2021</completion_date>
  <primary_completion_date type="Actual">January 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>corneal density in throid patients</measure>
    <time_frame>up to 12 weeks</time_frame>
    <description>corneal density values according to type of thyroid disorder</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">60</enrollment>
  <condition>Thyroid Disorder</condition>
  <condition>Corneal Opacity</condition>
  <arm_group>
    <arm_group_label>Hypothyroidia</arm_group_label>
    <description>20 subjects diagnosed with hypothyroidism</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Hyperthyroidia</arm_group_label>
    <description>20 subjects diagnosed with hyperthyroidism</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy</arm_group_label>
    <description>20 age-matched healthy control subjects</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        20 patients diagnosed hypthyroidia ,20 patients diagnosed hyperthyroidia ,20 age matched&#xD;
        healthy individuals&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Thyroid hormone disorder patients with a novel diagnosis&#xD;
&#xD;
          -  Age-matched healthy individuals without any systemic disorder (e.g., diabetes&#xD;
             mellitus, hypertension, rhematoid artritis, asthma etc.)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Having a spherical or cylindrical refractive error of &gt;1.0 degrees,&#xD;
&#xD;
          -  Congenital corneal dystrophies, corneal ectasia, corneal ulcers or scars, keratitis,&#xD;
             ocular surface infections, keratoconus,&#xD;
&#xD;
          -  A history of ocular trauma,&#xD;
&#xD;
          -  Uveitis,&#xD;
&#xD;
          -  Glaucoma,&#xD;
&#xD;
          -  A history of contact lens wear,&#xD;
&#xD;
          -  A history of ocular surgery,&#xD;
&#xD;
          -  Dry eye diseases&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mehmet F Alakuş, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Sağlık Bilimleri Üniversitesi Gazi Yaşargil Training and Research Hospital</name>
      <address>
        <city>Diyarbakır</city>
        <zip>211100</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <results_reference>
    <citation>Cankurtaran V, Tekin K, Cakmak AI, Inanc M, Turgut FH. Assessment of corneal topographic, tomographic, densitometric, and biomechanical properties of Fabry patients with ocular manifestations. Graefes Arch Clin Exp Ophthalmol. 2020 May;258(5):1057-1064. doi: 10.1007/s00417-019-04593-8. Epub 2020 Jan 8.</citation>
    <PMID>31915973</PMID>
  </results_reference>
  <results_reference>
    <citation>Bilgihan K, Hondur A, Sul S, Ozturk S. Pregnancy-induced progression of keratoconus. Cornea. 2011 Sep;30(9):991-4. doi: 10.1097/ICO.0b013e3182068adc.</citation>
    <PMID>21705880</PMID>
  </results_reference>
  <results_reference>
    <citation>Villani E, Viola F, Sala R, Salvi M, Mapelli C, Currò N, Vannucchi G, Beck-Peccoz P, Ratiglia R. Corneal involvement in Graves' orbitopathy: an in vivo confocal study. Invest Ophthalmol Vis Sci. 2010 Sep;51(9):4574-8. doi: 10.1167/iovs.10-5380. Epub 2010 Apr 30.</citation>
    <PMID>20435595</PMID>
  </results_reference>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>January 31, 2021</study_first_submitted>
  <study_first_submitted_qc>February 10, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 12, 2021</study_first_posted>
  <last_update_submitted>February 12, 2021</last_update_submitted>
  <last_update_submitted_qc>February 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital</investigator_affiliation>
    <investigator_full_name>Mehmet Fuat Alakuş</investigator_full_name>
    <investigator_title>assistant professor</investigator_title>
  </responsible_party>
  <keyword>Thyroid disorder</keyword>
  <keyword>Corneal opacity</keyword>
  <keyword>Corneal aberrations</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Corneal Opacity</mesh_term>
    <mesh_term>Thyroid Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

